Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers

BACKGROUND: The status of the EGFR and HER2-neu genes has not been fully defined in ovarian cancer. An integrated analysis of both genes could help define the proportion of patients that would potentially benefit from targeted therapies. METHODS: We determined the tumour mutation status of the entir...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeij, Joanna, Teugels, Erik, Bourgain, Claire, Xiangming, Ji, in 't Veld, Peter, Ghislain, Vanessa, Neyns, Bart, De Grève, Jacques
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266762/
https://www.ncbi.nlm.nih.gov/pubmed/18182111
http://dx.doi.org/10.1186/1471-2407-8-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266762/
https://www.ncbi.nlm.nih.gov/pubmed/18182111
http://dx.doi.org/10.1186/1471-2407-8-3

Ejemplares similares